Five Prime Therapeutics (FPRX) Misses Q1 EPS by 8c

Five Prime Therapeutics (NASDAQ: FPRX) reported Q1 EPS of ($0.63), $0.08 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Five Prime Therapeutics (FPRX) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• Tesla to launch Cybercab in Austin this month - report